Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

163-191 (Activation loop from InterPro)

Target domain

17-291 (Protein kinase domain)

Relief mechanism

Assay

Autoinhibited structure

Activated structure

5 structures for O95747

Entry ID Method Resolution Chain Position Source
2V3S X-ray 170 A A/B 433-527 PDB
2VWI X-ray 215 A A/B/C/D 1-303 PDB
3DAK X-ray 225 A A/B/C/D 6-295 PDB
7OKW X-ray 162 A A/B 423-527 PDB
AF-O95747-F1 Predicted AlphaFoldDB

296 variants for O95747

Variant ID(s) Position Change Description Diseaes Association Provenance
CA352137813
rs1217690582
2 S>F No ClinGen
gnomAD
rs780215814
CA2316267
2 S>P No ClinGen
ExAC
gnomAD
rs457661
CA2316268
3 E>D No ClinGen
ExAC
TOPMed
gnomAD
CA352137827
rs1225194943
4 D>E No ClinGen
gnomAD
CA352137821
rs1487409831
4 D>N No ClinGen
gnomAD
CA72898815
rs868322856
5 S>* No ClinGen
Ensembl
CA72898808
rs1050863016
5 S>P No ClinGen
Ensembl
CA72898825
rs1021823020
6 S>T No ClinGen
TOPMed
rs967136834
CA72898830
7 A>T No ClinGen
TOPMed
rs545168129
CA2316270
7 A>V No ClinGen
1000Genomes
ExAC
gnomAD
rs749182199
CA2316271
10 W>* No ClinGen
ExAC
gnomAD
CA72898866
rs867232819
12 I>S No ClinGen
Ensembl
rs774248337
CA2316273
13 N>S No ClinGen
ExAC
TOPMed
gnomAD
rs759376560
CA2316275
15 D>E No ClinGen
ExAC
TOPMed
gnomAD
CA352137891
rs1325289302
15 D>N No ClinGen
gnomAD
rs1226906632
CA352137919
18 E>D No ClinGen
TOPMed
gnomAD
CA352137921
rs1435726525
19 L>V No ClinGen
TOPMed
gnomAD
rs1302847738
CA352137930
20 Q>L No ClinGen
TOPMed
rs775271026
CA2316276
22 V>M No ClinGen
ExAC
TOPMed
gnomAD
CA352100712
rs1268336812
27 A>T No ClinGen
TOPMed
rs1188967434
CA352100842
34 A>V No ClinGen
gnomAD
CA72882825
rs552561847
35 Y>C No ClinGen
1000Genomes
ExAC
gnomAD
rs552561847
CA2316306
35 Y>S No ClinGen
1000Genomes
ExAC
gnomAD
rs138580801
CA2316307
37 A>D No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1425492233
CA352100863
38 P>S No ClinGen
gnomAD
rs779382388
CA72882880
47 R>Q No ClinGen
Ensembl
rs1051857953
CA72882867
47 R>W No ClinGen
Ensembl
CA2316310
rs745736039
48 I>V No ClinGen
ExAC
gnomAD
rs1559502914
CA352100987
55 T>I No ClinGen
Ensembl
rs888899542
CA72882884
57 M>V No ClinGen
Ensembl
rs943585565
CA72882887
58 D>G No ClinGen
TOPMed
TCGA novel 59 E>A Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA352101021
rs1334869560
60 L>F No ClinGen
gnomAD
rs1575321471
CA352104249
63 E>K No ClinGen
Ensembl
rs756270734
CA2316328
66 A>V No ClinGen
ExAC
TOPMed
gnomAD
CA352104362
rs1575321483
67 M>V No ClinGen
Ensembl
rs1259331334
CA352104488
70 C>Y No ClinGen
gnomAD
CA352104625
rs1422999486
74 N>H No ClinGen
TOPMed
CA2316330
rs750413522
75 I>T No ClinGen
ExAC
TOPMed
gnomAD
rs1258246873
CA352104719
77 S>Y No ClinGen
TOPMed
CA352104815
rs1193857731
80 T>I No ClinGen
gnomAD
rs1480228300
CA352104886
83 V>L No ClinGen
TOPMed
rs1419916937
CA352104908
84 V>I No ClinGen
gnomAD
rs754714205
CA2316334
86 D>V No ClinGen
ExAC
gnomAD
rs1575321547
CA352105136
91 V>F No ClinGen
Ensembl
CA352105171
rs1575321550
93 K>E No ClinGen
Ensembl
rs780962712
CA2316335
97 G>E No ClinGen
ExAC
TOPMed
gnomAD
rs1373190488
CA352108126
98 G>A No ClinGen
gnomAD
TCGA novel 98 G>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1203335124
CA352108200
102 D>Y No ClinGen
TOPMed
CA352108405
rs1265157000
107 I>T No ClinGen
TOPMed
CA72893320
rs988386341
110 K>N No ClinGen
TOPMed
rs769044451
CA2316365
111 G>E No ClinGen
ExAC
gnomAD
rs1361197996
CA352108526
111 G>R No ClinGen
gnomAD
CA352108569
rs1269576776
112 E>D No ClinGen
TOPMed
CA352108535
rs1303581649
112 E>K No ClinGen
gnomAD
rs1232867769
CA352108681
115 S>N No ClinGen
gnomAD
rs776976832
CA2316367
116 G>E No ClinGen
ExAC
TOPMed
gnomAD
CA352108799
rs1489369304
117 V>G No ClinGen
gnomAD
TCGA novel 121 S>C Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs765160768
CA2316369
121 S>P No ClinGen
ExAC
gnomAD
rs949405988
CA72893348
125 T>A No ClinGen
TOPMed
gnomAD
rs751527084
CA2316370
125 T>M No ClinGen
ExAC
gnomAD
CA72893362
rs982645009
126 I>M No ClinGen
gnomAD
CA72893356
rs750858309
COSM3945431
COSM3945430
126 I>V lung [Cosmic] No ClinGen
cosmic curated
Ensembl
CA72893366
rs926710398
COSM3664625
COSM3664624
128 R>* NS [Cosmic] No ClinGen
cosmic curated
Ensembl
rs1379993593
CA352109156
128 R>Q Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
TCGA novel 133 G>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA72893390
rs1037511366
135 E>D No ClinGen
Ensembl
rs752529090
CA352109612
140 N>K No ClinGen
ExAC
TOPMed
gnomAD
CA2316375
rs777470323
144 H>Q No ClinGen
ExAC
gnomAD
rs755890218
CA2316374
144 H>Y No ClinGen
ExAC
gnomAD
rs1458698850
CA352116683
151 N>K No ClinGen
gnomAD
rs1270768774
CA352116677
151 N>S No ClinGen
gnomAD
CA352116687
rs1178659323
152 I>V No ClinGen
gnomAD
CA352116706
rs1247334392
153 L>P No ClinGen
TOPMed
CA2316408
rs189939988
159 S>L No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs1042664306
CA72911381
167 V>I No ClinGen
TOPMed
gnomAD
rs1559518421
CA352118501
168 S>G No ClinGen
Ensembl
rs1559518424
CA352118515
169 A>G No ClinGen
Ensembl
rs1559518427 171 L>F Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No NCI-TCGA
CA2316429
rs756496384
172 A>E No ClinGen
ExAC
gnomAD
CA72911385
rs2650093
172 A>P No ClinGen
Ensembl
rs778926610
CA2316433
177 I>V No ClinGen
ExAC
TOPMed
gnomAD
COSM1422710
COSM1422709
CA352118784
rs1296395342
179 R>Q large_intestine Variant assessed as Somatic; impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
NCI-TCGA
TOPMed
rs1371453875
CA352118812
180 N>K No ClinGen
gnomAD
CA72911420
rs2936810
181 K>* No ClinGen
Ensembl
rs201145646
CA2316434
181 K>R No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA352118840
rs1364559194
182 V>M No ClinGen
TOPMed
CA2316435
rs768633823
184 K>R No ClinGen
ExAC
gnomAD
CA72911430
rs902855725
186 F>L No ClinGen
TOPMed
rs776621148
CA2316436
187 V>I No ClinGen
ExAC
gnomAD
CA352118942
rs776621148
187 V>L No ClinGen
ExAC
gnomAD
CA72911445
rs998513186
189 T>S No ClinGen
TOPMed
gnomAD
rs761576446
CA2316438
190 P>H No ClinGen
ExAC
TOPMed
gnomAD
rs761576446
CA72911449
190 P>L No ClinGen
ExAC
TOPMed
gnomAD
CA352119055
rs1200680512
192 W>L No ClinGen
TOPMed
rs148501279
CA2316451
202 R>C No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1311024425
CA352119694
202 R>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
CA2316453
rs746001398
205 D>G No ClinGen
ExAC
gnomAD
rs934019667
CA352119779
205 D>N No ClinGen
TOPMed
CA72912863
rs934019667
205 D>Y No ClinGen
TOPMed
rs1291235013
CA352119918
209 D>G No ClinGen
gnomAD
CA2316454
rs772139791
209 D>N No ClinGen
ExAC
gnomAD
CA352119987
rs1354638025
212 S>N No ClinGen
gnomAD
rs145105894
CA2316455
218 I>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
TCGA novel 219 E>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1233643126
CA352120198
222 T>A No ClinGen
TOPMed
gnomAD
rs773022296
CA2316458
222 T>I No ClinGen
ExAC
gnomAD
rs913448864
CA72912910
224 A>T No ClinGen
Ensembl
rs762812182
CA2316459
224 A>V Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
rs1180184058
CA352120237
227 Y>C No ClinGen
gnomAD
rs1315338353
CA352120245
228 H>R No ClinGen
gnomAD
TCGA novel 229 K>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA352120288
rs1475844937
231 P>L No ClinGen
gnomAD
CA352120315
rs1157317775
233 M>R No ClinGen
TOPMed
CA2316473
rs748069034
235 V>A No ClinGen
ExAC
gnomAD
rs1296116472
CA352121295
237 M>V No ClinGen
TOPMed
gnomAD
rs745877149
CA72913358
239 T>A No ClinGen
Ensembl
CA352121354
rs374106391
240 L>V No ClinGen
ESP
ExAC
gnomAD
rs770845634
CA2316477
243 D>G No ClinGen
ExAC
gnomAD
rs1415525011
CA352121474
244 P>A No ClinGen
TOPMed
gnomAD
rs967688919
CA72913378
244 P>L No ClinGen
Ensembl
CA352121513
rs1296439730
246 S>P No ClinGen
TOPMed
gnomAD
rs1306972803
CA352121584
250 G>D No ClinGen
gnomAD
CA2316479
rs745468647
253 D>N No ClinGen
ExAC
gnomAD
rs1258015244
CA352121692
254 K>N No ClinGen
gnomAD
TCGA novel 255 E>K Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 260 Y>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs775103796
CA2316481
264 F>Y No ClinGen
ExAC
gnomAD
rs1167622259
CA352122207
275 D>E No ClinGen
gnomAD
CA352122190
rs1261878297
275 D>N No ClinGen
gnomAD
rs1427440846
CA352122204
275 D>V No ClinGen
gnomAD
rs1434934825
CA352122222
276 P>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA352122210
rs1396522157
276 P>T No ClinGen
gnomAD
CA352122252
rs1345216496
277 E>A No ClinGen
TOPMed
gnomAD
CA352122241
rs1172859188
277 E>K No ClinGen
gnomAD
CA352122287
rs1432869913
278 K>I No ClinGen
gnomAD
CA352123064
rs1274561793
282 A>T No ClinGen
gnomAD
CA352123100
rs1318851210
282 A>V No ClinGen
gnomAD
CA352123103
rs1468557929
283 A>T No ClinGen
gnomAD
rs765632096
CA72916468
283 A>V No ClinGen
Ensembl
rs762262863
CA2316503
284 E>D No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 286 L>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA2316504
rs770177968
287 R>G No ClinGen
ExAC
gnomAD
rs1406969795
CA352123192
287 R>K No ClinGen
gnomAD
rs773609974
CA2316505
288 H>Q No ClinGen
ExAC
gnomAD
CA72916488
rs1057068960
289 K>R No ClinGen
TOPMed
gnomAD
rs774655961
CA2316529
297 K>R No ClinGen
ExAC
TOPMed
gnomAD
rs375186809
CA2316530
301 Q>L No ClinGen
ESP
ExAC
gnomAD
TCGA novel 303 K>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1339550610
CA352123597
304 T>A No ClinGen
gnomAD
CA2316531
rs6599079
VAR_023232
304 T>I No ClinGen
UniProt
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
TCGA novel 306 Q>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA352123678
rs1485327340
307 R>K No ClinGen
gnomAD
CA2316533
rs760822205
307 R>S No ClinGen
ExAC
gnomAD
CA2316536
rs758221566
310 T>A No ClinGen
ExAC
TOPMed
gnomAD
CA2316537
rs142820192
311 I>M No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1174729097
CA352123750
313 E>G No ClinGen
gnomAD
rs1436798799
CA352123742
313 E>K Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA352123761
rs1375184332
314 R>K No ClinGen
gnomAD
CA352123774
rs1320876775
315 A>E No ClinGen
gnomAD
CA2316538
rs751259596
315 A>T No ClinGen
ExAC
gnomAD
CA2316539
rs754668810
316 K>E No ClinGen
ExAC
gnomAD
CA72916814
rs1008993948
317 K>Q No ClinGen
Ensembl
rs767226612
CA2316558
319 R>Q No ClinGen
ExAC
gnomAD
COSM3392371
rs895952611
CA352125774
COSM3392372
319 R>W pancreas Variant assessed as Somatic; impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
NCI-TCGA
TOPMed
gnomAD
rs755636046
CA2316560
327 R>C No ClinGen
ExAC
gnomAD
rs777107244
COSM1186237
CA2316561
327 R>H lung Variant assessed as Somatic; 0.0 impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
ExAC
NCI-TCGA
TOPMed
gnomAD
rs372927731
CA72920014
330 K>R No ClinGen
ESP
TOPMed
CA352126089
rs1252616587
333 D>G No ClinGen
gnomAD
CA2316562
rs748799742
334 G>R No ClinGen
ExAC
TOPMed
gnomAD
rs757750921
CA2316563
335 G>D No ClinGen
ExAC
TOPMed
gnomAD
rs1364708444
CA352126183
337 E>G No ClinGen
gnomAD
rs1364708444
CA352126181
337 E>V No ClinGen
gnomAD
rs1157619252
CA352126188
338 W>G No ClinGen
gnomAD
rs1420604041
CA352126210
339 S>G No ClinGen
gnomAD
CA2316564
rs551708596
339 S>I No ClinGen
1000Genomes
ExAC
gnomAD
CA352126226
rs746299066
339 S>R No ClinGen
ExAC
gnomAD
rs1575365806
CA352126236
340 D>H No ClinGen
Ensembl
CA352126342
rs1393354505
344 D>E No ClinGen
TOPMed
gnomAD
CA352126422
rs1559525177
347 S>N No ClinGen
Ensembl
TCGA novel 350 G>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs772495728
CA2316566
354 I>V No ClinGen
ExAC
TOPMed
gnomAD
rs775863821
CA2316567
355 S>A No ClinGen
ExAC
gnomAD
COSM163221
rs747176039
CA2316568
355 S>L breast [Cosmic] No ClinGen
cosmic curated
ExAC
gnomAD
rs1392952930
CA352126740
356 Q>* No ClinGen
TOPMed
CA352097715
rs769847615
361 R>* Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
rs374794688
CA72873085
364 E>D No ClinGen
Ensembl
rs369634764
CA2316591
366 I>M No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs991262562
CA72873089
366 I>V No ClinGen
TOPMed
gnomAD
rs917553702
CA72873119
367 S>A No ClinGen
TOPMed
gnomAD
rs917553702
CA72873113
367 S>T No ClinGen
TOPMed
gnomAD
rs1197495868
CA352097852
369 S>T No ClinGen
TOPMed
CA2316594
rs771966064
370 E>G No ClinGen
ExAC
TOPMed
gnomAD
rs769786839
CA2316609
371 L>F No ClinGen
ExAC
TOPMed
gnomAD
CA2316608
rs769786839
371 L>I No ClinGen
ExAC
TOPMed
gnomAD
rs772055910
CA2316611
373 P>A No ClinGen
ExAC
gnomAD
CA352098692
rs1465426673
375 T>A No ClinGen
TOPMed
CA2316612
rs775400116
377 P>L No ClinGen
ExAC
TOPMed
gnomAD
rs1175022268
CA352098751
378 V>M No ClinGen
gnomAD
rs1173133062
CA352098775
379 G>D No ClinGen
TOPMed
CA352098806
rs1455282660
381 L>F No ClinGen
gnomAD
rs1413740765
CA352098812
382 L>F No ClinGen
TOPMed
rs1387964926
CA352098849
383 Q>H No ClinGen
TOPMed
gnomAD
CA352098869
rs1575375481
384 V>A No ClinGen
Ensembl
CA2316615
rs776167759
385 P>A No ClinGen
ExAC
gnomAD
CA352098903
rs1559528644
386 E>G No ClinGen
Ensembl
CA352098892
rs1305933296
386 E>Q No ClinGen
gnomAD
TCGA novel 389 S>F Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs761482215
CA2316616
390 A>T No ClinGen
ExAC
gnomAD
CA2316617
rs764761772
390 A>V No ClinGen
ExAC
gnomAD
rs1177689077
CA352098985
391 H>R No ClinGen
TOPMed
CA2316618
rs201009720
391 H>Y No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA2316620
rs767063485
393 P>R No ClinGen
ExAC
gnomAD
rs974723559
CA72874743
393 P>S No ClinGen
Ensembl
rs376982746
CA72874746
395 P>Q No ClinGen
ESP
TOPMed
gnomAD
rs369899701
CA2316621
396 A>D No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1206207661
CA352099140
400 A>V No ClinGen
gnomAD
CA352099195
rs1319578333
404 T>I No ClinGen
gnomAD
rs912700802
CA72874776
404 T>S No ClinGen
TOPMed
gnomAD
CA352099199
rs1468633150
405 Q>E No ClinGen
gnomAD
CA2316624
rs752894235
408 L>F No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 408 L>P Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1420853122
CA352099258
410 P>A No ClinGen
gnomAD
CA72874790
rs113919536
412 A>S No ClinGen
ExAC
TOPMed
gnomAD
CA2316627
rs113919536
412 A>T No ClinGen
ExAC
TOPMed
gnomAD
CA352099300
rs1327938811
413 E>G No ClinGen
gnomAD
rs1468582542
CA352099350
416 K>R No ClinGen
gnomAD
rs562635647
CA72874830
417 T>P No ClinGen
Ensembl
CA352099401
rs1292188052
418 A>V No ClinGen
gnomAD
rs1451631468
CA352099702
422 S>F No ClinGen
TOPMed
rs35295772
VAR_025181
CA2316645
425 S>T No ClinGen
UniProt
1000Genomes
ExAC
dbSNP
gnomAD
CA2316646
rs754000162
426 G>D No ClinGen
ExAC
gnomAD
rs143136743
CA2316647
428 Q>P No ClinGen
ESP
ExAC
TOPMed
gnomAD
COSM1422714
CA2316649
COSM1422715
rs745902557
433 P>Q large_intestine [Cosmic] No ClinGen
cosmic curated
ExAC
gnomAD
VAR_040969 433 P>S a metastatic melanoma sample; somatic mutation [UniProt] No UniProt
CA2316650
rs754988370
434 I>V No ClinGen
ExAC
TOPMed
gnomAD
CA352100122
rs1410743876
440 L>S Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA2316653
rs769649864
441 R>K No ClinGen
ExAC
gnomAD
rs2588458
CA72877581
444 K>Q No ClinGen
Ensembl
CA352101532
rs1346433538
448 N>S No ClinGen
gnomAD
CA352101606
rs1435130969
451 R>* Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs1296423815
COSM1044171
COSM1044172
CA352101610
451 R>Q Variant assessed as Somatic; 0.0 impact. large_intestine endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
gnomAD
CA72877591
rs774370241
453 E>D No ClinGen
Ensembl
CA352101757
rs1207402579
456 P>L No ClinGen
TOPMed
rs1016963523
CA72877602
456 P>S No ClinGen
TOPMed
gnomAD
rs770757632
CA2316675
457 G>R No ClinGen
ExAC
gnomAD
rs1300635762
CA352102413
459 D>V No ClinGen
gnomAD
rs769206279
CA2316700
461 A>T No ClinGen
ExAC
TOPMed
gnomAD
rs1374173557
CA352102533
462 E>K No ClinGen
gnomAD
CA352102760
rs1472548142
COSM1315911
COSM1315910
469 I>V haematopoietic_and_lymphoid_tissue [Cosmic] No ClinGen
cosmic curated
gnomAD
CA2316704
rs145431865
475 D>N No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
COSM2986092
COSM2986091
CA2316706
rs766592272
476 G>R Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
TOPMed
gnomAD
CA352103196
rs1384878495
481 I>M No ClinGen
gnomAD
CA352103190
rs1575379862
481 I>T No ClinGen
Ensembl
CA72879180
rs1047929290
483 A>S No ClinGen
Ensembl
rs759699767
CA2316728
484 A>G No ClinGen
ExAC
gnomAD
rs1470224021
CA352103744
487 Q>H No ClinGen
TOPMed
rs1194762500
CA352103729
487 Q>R No ClinGen
TOPMed
CA72879194
rs112280434
490 V>A No ClinGen
Ensembl
rs1254834800
CA352103856
491 E>D No ClinGen
gnomAD
rs767656231
CA2316729
491 E>G No ClinGen
ExAC
gnomAD
rs1008813523
CA72879218
493 P>L No ClinGen
Ensembl
CA72879210
rs887320930
493 P>S No ClinGen
Ensembl
CA352104044
rs765195729
497 R>L No ClinGen
ExAC
gnomAD
rs765195729
CA2316733
497 R>P No ClinGen
ExAC
gnomAD
rs765195729
CA2316732
497 R>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs1444372436
CA352104054
498 S>C No ClinGen
gnomAD
rs758205017
CA2316734
500 T>A No ClinGen
ExAC
TOPMed
gnomAD
CA352104113
rs1166420798
500 T>S No ClinGen
gnomAD
CA352104385
rs1388271523
504 A>S No ClinGen
gnomAD
rs1388271523
CA352104378
504 A>T No ClinGen
gnomAD
CA352104424
rs1433135948
506 G>A No ClinGen
gnomAD
rs1295707091
CA352104433
507 V>F No ClinGen
gnomAD
CA72879509
rs191643511
508 E>K No ClinGen
1000Genomes
TOPMed
gnomAD
CA352104451
rs191643511
508 E>Q No ClinGen
1000Genomes
TOPMed
gnomAD
rs1559531557
CA352104514
510 S>L No ClinGen
Ensembl
CA352104544
rs1159523908
511 D>G No ClinGen
TOPMed
CA2316754
rs557160772
511 D>H No ClinGen
1000Genomes
ExAC
gnomAD
rs528270834
CA2316755
512 I>T No ClinGen
ExAC
TOPMed
gnomAD
CA72879515
rs1007940574
512 I>V No ClinGen
TOPMed
rs1250929170
CA352104586
513 P>S No ClinGen
TOPMed
rs755028275
COSM1647674
CA2316756
COSM730992
515 D>N lung Variant assessed as Somatic; 0.0 impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
ExAC
NCI-TCGA
gnomAD
rs1328112515
CA352104684
516 G>D No ClinGen
gnomAD
rs778154420
CA2316758
519 I>R No ClinGen
ExAC
gnomAD
CA72879533
rs757709802
519 I>V No ClinGen
Ensembl
rs971239388
CA72879534
520 G>A No ClinGen
gnomAD
CA352104789
rs971239388
520 G>E No ClinGen
gnomAD
TCGA novel 520 G>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1268072416
CA352104806
521 F>I No ClinGen
TOPMed
rs982201179
CA72879535
522 A>V No ClinGen
Ensembl
CA2316760
rs757727581
524 L>V No ClinGen
ExAC
gnomAD
CA352104920
rs1411309028
525 S>G No ClinGen
gnomAD
CA352104964
rs1455666543
525 S>R No ClinGen
gnomAD
rs1484999536
CA352104999
527 S>T No ClinGen
TOPMed

No associated diseases with O95747

3 regional properties for O95747

Type Name Position InterPro Accession
domain Protein kinase domain 17 - 291 IPR000719
binding_site Protein kinase, ATP binding site 23 - 46 IPR017441
domain Serine/threonine-protein kinase OSR1/WNK, CCT domain 434 - 491 IPR024678

Functions

Description
EC Number 2.7.11.1 Protein-serine/threonine kinases
Subcellular Localization
  • Cytoplasm
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

3 GO annotations of cellular component

Name Definition
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
cytosol The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
extracellular exosome A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.

6 GO annotations of molecular function

Name Definition
ATP binding Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
identical protein binding Binding to an identical protein or proteins.
magnesium ion binding Binding to a magnesium (Mg) ion.
protein kinase binding Binding to a protein kinase, any enzyme that catalyzes the transfer of a phosphate group, usually from ATP, to a protein substrate.
protein serine kinase activity Catalysis of the reactions: ATP + protein serine = ADP + protein serine phosphate.
protein serine/threonine kinase activity Catalysis of the reactions: ATP + protein serine = ADP + protein serine phosphate, and ATP + protein threonine = ADP + protein threonine phosphate.

14 GO annotations of biological process

Name Definition
cellular hypotonic response Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of detection of, or exposure to, a hypotonic environment, i.e. an environment with a lower concentration of solutes than the organism or cell.
cellular response to chemokine Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a chemokine stimulus.
chemokine (C-C motif) ligand 21 signaling pathway The series of molecular signals initiated by the binding of the C-C chemokine CCL21 to its receptor on the surface of a target cell, and ending with the regulation of a downstream cellular process, e.g. transcription.
chemokine (C-X-C motif) ligand 12 signaling pathway The series of molecular signals initiated by the binding of the chemokine CXCL12 to its receptor on the surface of a target cell, and ending with the regulation of a downstream cellular process, e.g. transcription.
intracellular signal transduction The process in which a signal is passed on to downstream components within the cell, which become activated themselves to further propagate the signal and finally trigger a change in the function or state of the cell.
negative regulation of potassium ion transmembrane transporter activity Any process that stops, prevents or reduces the frequency, rate or extent of potassium ion transmembrane transporter activity.
osmosensory signaling pathway The series of molecular signals initiated in response to osmotic change.
peptidyl-threonine phosphorylation The phosphorylation of peptidyl-threonine to form peptidyl-O-phospho-L-threonine.
positive regulation of T cell chemotaxis Any process that increases the rate, frequency or extent of T cell chemotaxis. T cell chemotaxis is the directed movement of a T cell in response to an external stimulus.
protein autophosphorylation The phosphorylation by a protein of one or more of its own amino acid residues (cis-autophosphorylation), or residues on an identical protein (trans-autophosphorylation).
protein phosphorylation The process of introducing a phosphate group on to a protein.
response to oxidative stress Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of oxidative stress, a state often resulting from exposure to high levels of reactive oxygen species, e.g. superoxide anions, hydrogen peroxide (H2O2), and hydroxyl radicals.
response to xenobiotic stimulus Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a xenobiotic, a compound foreign to the organim exposed to it. It may be synthesized by another organism (like ampicilin) or it can be a synthetic chemical.
signal transduction The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.

20 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q9C0K7 STRADB STE20-related kinase adapter protein beta Homo sapiens (Human) PR
Q7RTN6 STRADA STE20-related kinase adapter protein alpha Homo sapiens (Human) PR
Q9H2G2 SLK STE20-like serine/threonine-protein kinase Homo sapiens (Human) PR
O94804 STK10 Serine/threonine-protein kinase 10 Homo sapiens (Human) PR
Q9UEW8 STK39 STE20/SPS1-related proline-alanine-rich protein kinase Homo sapiens (Human) PR
Q9Y4K4 MAP4K5 Mitogen-activated protein kinase kinase kinase kinase 5 Homo sapiens (Human) PR
Q92918 MAP4K1 Mitogen-activated protein kinase kinase kinase kinase 1 Homo sapiens (Human) EV
Q12851 MAP4K2 Mitogen-activated protein kinase kinase kinase kinase 2 Homo sapiens (Human) EV
Q8IVH8 MAP4K3 Mitogen-activated protein kinase kinase kinase kinase 3 Homo sapiens (Human) SS
Q9P289 STK26 Serine/threonine-protein kinase 26 Homo sapiens (Human) PR
Q9Y6E0 STK24 Serine/threonine-protein kinase 24 Homo sapiens (Human) PR
O00506 STK25 Serine/threonine-protein kinase 25 Homo sapiens (Human) PR
Q8K4T3 Stradb STE20-related kinase adapter protein beta Mus musculus (Mouse) PR
Q3UUJ4 Strada STE20-related kinase adapter protein alpha Mus musculus (Mouse) PR
Q6P9R2 Oxsr1 Serine/threonine-protein kinase OSR1 Mus musculus (Mouse) PR
Q9Z1W9 Stk39 STE20/SPS1-related proline-alanine-rich protein kinase Mus musculus (Mouse) PR
Q863I2 OXSR1 Serine/threonine-protein kinase OSR1 Sus scrofa (Pig) PR
Q7TNZ6 Strada STE20-related kinase adapter protein alpha Rattus norvegicus (Rat) PR
O88506 Stk39 STE20/SPS1-related proline-alanine-rich protein kinase Rattus norvegicus (Rat) PR
O23304 BLUS1 Serine/threonine-protein kinase BLUS1 Arabidopsis thaliana (Mouse-ear cress) PR
10 20 30 40 50 60
MSEDSSALPW SINRDDYELQ EVIGSGATAV VQAAYCAPKK EKVAIKRINL EKCQTSMDEL
70 80 90 100 110 120
LKEIQAMSQC HHPNIVSYYT SFVVKDELWL VMKLLSGGSV LDIIKHIVAK GEHKSGVLDE
130 140 150 160 170 180
STIATILREV LEGLEYLHKN GQIHRDVKAG NILLGEDGSV QIADFGVSAF LATGGDITRN
190 200 210 220 230 240
KVRKTFVGTP CWMAPEVMEQ VRGYDFKADI WSFGITAIEL ATGAAPYHKY PPMKVLMLTL
250 260 270 280 290 300
QNDPPSLETG VQDKEMLKKY GKSFRKMISL CLQKDPEKRP TAAELLRHKF FQKAKNKEFL
310 320 330 340 350 360
QEKTLQRAPT ISERAKKVRR VPGSSGRLHK TEDGGWEWSD DEFDEESEEG KAAISQLRSP
370 380 390 400 410 420
RVKESISNSE LFPTTDPVGT LLQVPEQISA HLPQPAGQIA TQPTQVSLPP TAEPAKTAQA
430 440 450 460 470 480
LSSGSGSQET KIPISLVLRL RNSKKELNDI RFEFTPGRDT AEGVSQELIS AGLVDGRDLV
490 500 510 520
IVAANLQKIV EEPQSNRSVT FKLASGVEGS DIPDDGKLIG FAQLSIS